Knockout Round is Closed!

Thank you for all who are voting! This stage of 16 was the toughest round yet, but only 8 drugs will advance one step closer to the title of "Safest Drug Profile" . Can you pick which drug will win it all?  Check out our 4 new matchups in our quarterfinal round. Will Victoza be able to overcome Xeljanz? How will Incivek perform against Crestor?

Play Along Now!

Players of the Match: Both Louis Lima and Sathish Kumar had the highest score of correct answers. Good Job!

Check below to see the results from last weeks matchups and see how others voted.

Surprised by any of the answers? See the actual RxScore for each of these drugs by registering for a complimentary 7 day trial of AdverseEvents Explorer!




Eliquis vs. Onglyza

Advances to Quaterfinals: Onglyza


Eliquis vs. Onglyza

See all RxScores

Coumadin vs. Victoza

Advances to Quaterfinals: Vicotza


Coumadin vs Victoza

See all RxScores

Sovaldi vs. Gilenya

Advances to Quaterfinals: Sovaldi


Sovaldi vs Gilenya

See all RxScores

Tysabri vs. Incivek

Advances to Quarterfinals: Incivek


 Tysabri vs Incivek

See all RxScores

Crestor vs. Brilinta

Advances to Quarterfinals: Crestor


 Crestor vs Brilinta

See all RxScores

Enbrel vs. Symbicort

Advances to Quarterfinals: Enbrel


 Enbrel vs. Symbicort

See all RxScores

Plavix vs. Simcor

Advances to Quarterfinals: Simcor


 Plavix vs Simcor

See all RxScores

Advair vs. Xeljanz

Advances to Quarterfinals: Xeljanz


 Advair vs. Xeljanz

See all RxScores



 


Jim Davis

Jim Davis

Executive Vice President

Jim Davis LinkedinJim Davis Twitter

 

Jim Davis

Written by Jim Davis

As Executive Vice President, Jim is responsible for the commercialization strategy for Advera Health Analytics.